StockMacro
Menu

Si-Bone

$23.73 +62% in 6 monthsMarket cap $1.1B

SIBN on XNAS, Health Care, SI-BONE, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 14% to $220.7M and shares gained 27% in a year, but free cash flow was -$4.2M.

  • WatchCapital spending rose 115% to $6.4M in the latest quarter

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Industry
Surgical & medical instruments & apparatus (Health Care)
Employees
376
Website
si-bone.com
Listed
Nasdaq, US
Last results
2 Nov 2026
Next results
expected around 11 Jan 2027 (an estimate: a year ago it reported on 12 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $55.7M, net loss $3.6M.
Quarter to 31 Dec 2021: revenue $25.2M, net income -$14.5MQuarter to 31 Dec 2021: revenue $25.2M, net income -$14.5MQuarter to 31 Mar 2022: revenue $22.4M, net income -$17.4MQuarter to 31 Mar 2022: revenue $22.4M, net income -$17.4MQuarter to 30 Jun 2022: revenue $25.6M, net income -$18.5MQuarter to 30 Jun 2022: revenue $25.6M, net income -$18.5MQuarter to 30 Sep 2022: revenue $26.4M, net income -$14.2MQuarter to 30 Sep 2022: revenue $26.4M, net income -$14.2MQuarter to 31 Dec 2022: revenue $32.0M, net income -$11.2MQuarter to 31 Dec 2022: revenue $32.0M, net income -$11.2MQuarter to 31 Mar 2023: revenue $32.7M, net income -$11.1MQuarter to 31 Mar 2023: revenue $32.7M, net income -$11.1MQuarter to 30 Jun 2023: revenue $33.3M, net income -$11.2MQuarter to 30 Jun 2023: revenue $33.3M, net income -$11.2MQuarter to 30 Sep 2023: revenue $34.0M, net income -$10.0MQuarter to 30 Sep 2023: revenue $34.0M, net income -$10.0MQuarter to 31 Dec 2023: revenue $38.9M, net income -$11.0MQuarter to 31 Dec 2023: revenue $38.9M, net income -$11.0MQuarter to 31 Mar 2024: revenue $37.9M, net income -$10.9MQuarter to 31 Mar 2024: revenue $37.9M, net income -$10.9MQuarter to 30 Jun 2024: revenue $40.0M, net income -$8.9MQuarter to 30 Jun 2024: revenue $40.0M, net income -$8.9MQuarter to 30 Sep 2024: revenue $40.3M, net income -$6.6MQuarter to 30 Sep 2024: revenue $40.3M, net income -$6.6MQuarter to 31 Dec 2024: revenue $49.0M, net income -$4.5MQuarter to 31 Dec 2024: revenue $49.0M, net income -$4.5MQuarter to 31 Mar 2025: revenue $47.3M, net income -$6.5MQuarter to 31 Mar 2025: revenue $47.3M, net income -$6.5MQuarter to 30 Jun 2025: revenue $48.6M, net income -$6.2MQuarter to 30 Jun 2025: revenue $48.6M, net income -$6.2MQuarter to 30 Sep 2025: revenue $48.7M, net income -$4.6MQuarter to 30 Sep 2025: revenue $48.7M, net income -$4.6MQuarter to 31 Dec 2025: revenue $56.3M, net income -$1.6MQuarter to 31 Dec 2025: revenue $56.3M, net income -$1.6MQuarter to 31 Mar 2026: revenue $52.6M, net income -$4.3MQuarter to 31 Mar 2026: revenue $52.6M, net income -$4.3MQuarter to 30 Jun 2026: revenue $56.0M, net income -$4.1MQuarter to 30 Jun 2026: revenue $56.0M, net income -$4.1MQuarter to 30 Sep 2026: revenue $55.7M, net income -$3.6MQuarter to 30 Sep 2026: revenue $55.7M, net income -$3.6M
31 Dec 2021RevenueNet incomeNet losstallest bar $56.3M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$55.7M-$3.6M
30 Jun 2026$56.0M-$4.1M
31 Mar 2026$52.6M-$4.3M
31 Dec 2025$56.3M-$1.6M
30 Sep 2025$48.7M-$4.6M
30 Jun 2025$48.6M-$6.2M
31 Mar 2025$47.3M-$6.5M
31 Dec 2024$49.0M-$4.5M
30 Sep 2024$40.3M-$6.6M
30 Jun 2024$40.0M-$8.9M
31 Mar 2024$37.9M-$10.9M
31 Dec 2023$38.9M-$11.0M
30 Sep 2023$34.0M-$10.0M
30 Jun 2023$33.3M-$11.2M
31 Mar 2023$32.7M-$11.1M
31 Dec 2022$32.0M-$11.2M
30 Sep 2022$26.4M-$14.2M
30 Jun 2022$25.6M-$18.5M
31 Mar 2022$22.4M-$17.4M
31 Dec 2021$25.2M-$14.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $220.7M $193.6M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +14% +13%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$13.7M -$21.8M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.31 -$0.51
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 79.4% 79.6% 60.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -7.6% -13.1% -8.3%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -6.2% -11.2% -10.1%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -7.7% -26.3%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$4.2M -$10.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $146.3M $145.7M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $35.7M $35.5M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$110.6M (net cash) -$110.2M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.19 0.31
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $4.09
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 28.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 4.9 2.3
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 4.4 2.5
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.8 2.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Si-BoneSIBN (this company) $1.1Bloss4.9+14%-6.2%
iRadimedIRMD $1.0B43.211.6+11%26.8%
Integra LifeSciencesIART $1.0B79.20.62+0.8%0.8%
AlphatecATEC $1.0Bloss1.2+15%-10.3%
SpyGlass PharmaSGP $1.0Bloss–––
Tandem Diabetes CareTNDM $1.2Bloss1.1+6.8%-4.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$7.1M

bought $0, sold $7.1M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+6.0%

177 13F filers vs 167

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

48.2M shares held by 13F filers (30 Sep 2026) of 45.1M outstanding (28 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

10%

4.5M shares sold short (30 Oct 2026) of 45.1M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.8

4.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-3.8%

4.7M shares sold short in the report before, 4.5M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

39%

39% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 54%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+14%

$55.7M vs $48.7M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

+115%

$6.4M vs $3.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$10K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

15

15 articles in the last 7 days; its usual week has 0.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

15 articles in the last 7 days; its usual week has 0.5: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Capital spending $6.4M, 2.2× a year earlier

Price $23.73 on 20 Nov 2026, +27% over 12 months (12-month range $11.61 to $25.60)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $14.3M in the last 12 months (the 12 months before: -$6.7M).
Revenue per quarter. Revenue $55.7M in the latest quarter, +14% on a year earlier.
Capital spending per quarter. Capital spending $6.4M in the latest quarter, +115% on a year earlier.
Institutional holders (13F filers). 177 13F filers reported holding it in the latest 13F quarter, +4.7% on a year earlier.
Lobbying spend. Lobbying spend: $10K published in the last 12 months, -50% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Nov 2026Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 6.4M vs usual 2.1M (2026-09-30); 2.2x the same period a year earlier
16 Jun 2026Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.5M (2026-05-29); 3.2x the same period a year earlier
2 Jun 2026Sharp changeShort interest spike: short interest spike, 5.7M vs usual 2.4M (2026-05-15); 3.5x the same period a year earlier
12 May 2026Sharp changeShort interest spike: short interest spike, 4.5M vs usual 2.4M (2026-04-30); 3.0x the same period a year earlier
28 Apr 2026Sharp changeShort interest spike: short interest spike, 4.6M vs usual 2.4M (2026-04-15); 3.1x the same period a year earlier
23 Feb 20268-K and other filingsDirector or officer change
23 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Jan 2026Lobbying filinglobbying engagement terminated (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
10 Nov 20258-K and other filingsDirector or officer change
10 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Aug 20258-K and other filingsDirector or officer change
4 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jul 2025Sharp changeLobbying on a new issue: lobbying on a new issue: MMM (2025-06-30)
3 Jul 2025Lobbying filingnew lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.)
5 Aug 20248-K and other filingsDirector or officer change
5 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
2 Jul 2024Sharp changeShort interest spike: short interest spike, 2.4M vs usual 1.0M (2024-06-14); 3.2x the same period a year earlier
18 Jun 2024Sharp changeShort interest spike: short interest spike, 2.7M vs usual 1.0M (2024-05-31); 3.1x the same period a year earlier
28 May 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 964K (2024-05-15); 3.6x the same period a year earlier
14 May 2024Sharp changeShort interest spike: short interest spike, 2.8M vs usual 964K (2024-04-30); 2.6x the same period a year earlier
30 Apr 2024Sharp changeShort interest spike: short interest spike, 2.6M vs usual 964K (2024-04-15); 2.1x the same period a year earlier
16 Apr 2024Sharp changeShort interest spike: short interest spike, 2.4M vs usual 964K (2024-03-28); 2.0x the same period a year earlier
2 Apr 2024Sharp changeShort interest spike: short interest spike, 2.5M vs usual 964K (2024-03-15); 2.3x the same period a year earlier
12 Mar 2024Sharp changeShort interest spike: short interest spike, 2.3M vs usual 964K (2024-02-29); 1.6x the same period a year earlier
5 Mar 2024Sharp changeShort interest spike: short interest spike, 2.0M vs usual 964K (2024-02-15); 1.4x the same period a year earlier
13 Feb 2024Sharp changeShort interest spike: short interest spike, 1.8M vs usual 964K (2024-01-31); 1.3x the same period a year earlier
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 60 vs usual 12 (2023-06-30); 5.5x the same period a year earlier
16 May 2023Sharp changeMany funds opening a new position: many funds opening a new position, 23 vs usual 12 (2023-03-31); 2.6x the same period a year earlier
9 May 2023Sharp changeQuarterly revenue change: quarterly revenue change, 32.7M vs usual 23.8M (2023-03-31); 1.5x the same period a year earlier
7 Mar 2023Sharp changeQuarterly revenue change: quarterly revenue change, 32.0M vs usual 22.4M (2022-12-31); 1.3x the same period a year earlier
10 Jan 20228-K and other filingsDirector or officer change
10 Jan 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Jan 2022: -$62K published
Month from 1 Feb 2022: -$296K published
Month from 1 Apr 2022: -$48K published
Month from 1 May 2022: -$295K published
Month from 1 Jun 2022: -$27K published
Month from 1 Jul 2022: -$44K published
Month from 1 Aug 2022: -$413K published
Month from 1 Oct 2022: -$56K published
Month from 1 Nov 2022: -$223K published
Month from 1 Jan 2023: -$66K published
Month from 1 Feb 2023: -$572K published
Month from 1 Mar 2023: -$750K published
Month from 1 Apr 2023: -$57K published
Month from 1 May 2023: -$6.7M published
Month from 1 Jun 2023: -$211K published
Month from 1 Jul 2023: -$79K published
Month from 1 Aug 2023: -$1.6M published
Month from 1 Sep 2023: -$452K published
Month from 1 Oct 2023: -$486K published
Month from 1 Nov 2023: -$328K published
Month from 1 Jan 2024: -$278K published
Month from 1 Feb 2024: -$1.2M published
Month from 1 Mar 2024: -$97K published
Month from 1 Apr 2024: -$103K published
Month from 1 May 2024: -$156K published
Month from 1 Jun 2024: -$4K published
Month from 1 Jul 2024: -$97K published
Month from 1 Aug 2024: -$282K published
Month from 1 Sep 2024: -$23K published
Month from 1 Oct 2024: -$102K published
Month from 1 Nov 2024: -$257K published
Month from 1 Jan 2025: -$125K published
Month from 1 Feb 2025: -$1.2M published
Month from 1 Apr 2025: -$138K published
Month from 1 May 2025: -$2.1M published
Month from 1 Jun 2025: -$64K published
Month from 1 Jul 2025: -$223K published
Month from 1 Aug 2025: -$542K published
Month from 1 Oct 2025: -$139K published
Month from 1 Nov 2025: -$2.2M published
Month from 1 Dec 2025: -$1.2M published
Month from 1 Jan 2026: -$668K published
Month from 1 Feb 2026: -$2.4M published
Month from 1 Mar 2026: -$57K published
Month from 1 Apr 2026: -$83K published
Month from 1 May 2026: -$347K published
Month from 1 Jun 2026: -$159K published
Month from 1 Jul 2026: -$108K published
Month from 1 Aug 2026: -$3.0M published
Month from 1 Sep 2026: -$378K published
Month from 1 Oct 2026: -$1.3M published
Month from 1 Nov 2026: -$4.7M published
Revenue per quarter
Quarter ended 31 Dec 2021: $25.2M, +14% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $22.4M, +9.8% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $25.6M, +15% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $26.4M, +19% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $32.0M, +27% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $32.7M, +46% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $33.3M, +30% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $34.0M, +29% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $38.9M, +22% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $37.9M, +16% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $40.0M, +20% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $40.3M, +19% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $49.0M, +26% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $47.3M, +25% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $48.6M, +22% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $48.7M, +21% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $56.3M, +15% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $52.6M, +11% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $56.0M, +15% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $55.7M, +14% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $1.8M, +117% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $2.3M, +15% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $2.0M, -9.7% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $3.6M, +744% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $1.7M, -6.5% on a year earlier; public on 3 Mar 2023
Quarter ended 31 Mar 2023: $2.6M, +13% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $2.7M, +36% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $1.4M, -60% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.1M, -34% on a year earlier; public on 28 Feb 2024
Quarter ended 31 Mar 2024: $2.1M, -19% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $3.1M, +15% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $3.0M, +115% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $2.3M, +107% on a year earlier; public on 26 Feb 2025
Quarter ended 31 Mar 2025: $2.1M, -0.5% on a year earlier; public on 7 May 2025
Quarter ended 30 Jun 2025: $2.1M, -33% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $3.0M, -2.7% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $1.3M, -43% on a year earlier; public on 25 Feb 2026
Quarter ended 31 Mar 2026: $1.1M, -48% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $1.5M, -26% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $6.4M, +115% on a year earlier; public on 4 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 109; public on 14 Feb 2022
31 Mar 2022 report: 105; public on 16 May 2022
30 Jun 2022 report: 104; public on 15 Aug 2022
30 Sep 2022 report: 102; public on 14 Nov 2022
31 Dec 2022 report: 97; public on 14 Feb 2023
31 Mar 2023 report: 114; public on 15 May 2023
30 Jun 2023 report: 160; public on 14 Aug 2023
30 Sep 2023 report: 141; public on 14 Nov 2023
31 Dec 2023 report: 150; public on 14 Feb 2024
31 Mar 2024 report: 142; public on 15 May 2024
30 Jun 2024 report: 131; public on 14 Aug 2024
30 Sep 2024 report: 127; public on 14 Nov 2024
31 Dec 2024 report: 142; public on 14 Feb 2025
31 Mar 2025 report: 155; public on 15 May 2025
30 Jun 2025 report: 172; public on 14 Aug 2025
30 Sep 2025 report: 169; public on 14 Nov 2025
31 Dec 2025 report: 177; public on 17 Feb 2026
31 Mar 2026 report: 174; public on 15 May 2026
30 Jun 2026 report: 167; public on 14 Aug 2026
30 Sep 2026 report: 177; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jul 2025: $10K published
Quarter from 1 Oct 2025: $10K published
Quarter from 1 Jan 2026: $10K published

What is unusual now

  • Made public in the last 90 days: it spent $6.4M on capital projects in the quarter ended 30 Sep 2026, 2.2× the same quarter last year.
  • Short interest spike: had 5.9M shares sold short in the 29 May 2026 report, 3.2× the same report last year Public on 10 Jun 2026.
  • Quarterly capital spending jump: spent $6.4M on capital projects in the quarter ended 30 Sep 2026, 2.2× the same quarter last year Public on 5 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $14.3M in the last 12 months (the 12 months before: -$6.7M).

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 16 sales, $7.1M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Nov 2026Laura FrancisChief Executive OfficerSellplanned in advance (10b5-1)16,854$23.31$393KForm 4
18 Nov 2026Michael A. PisetskyChief Legal OfficerSell3,725$23.32$87KForm 4
18 Nov 2026Anshul MaheshwariChief Op & Financial OfficerSellplanned in advance (10b5-1)6,380$23.29$149KForm 4
6 Nov 2026Laura FrancisChief Executive OfficerSellplanned in advance (10b5-1)75,000$25.30$1.9MForm 4
6 Nov 2026Michael A. PisetskySVP, Ops & Adm/Chief Legal OfrSellplanned in advance (10b5-1)36,241$24.80$899KForm 4
6 Nov 2026Anshul MaheshwariChief Op & Financial OfficerSellplanned in advance (10b5-1)3,247$25.00$81KForm 4
4 Nov 2026Jeffrey W DunnDirectorSellplanned in advance (10b5-1); after exercising options20,000$20.89$418KForm 4
2 Nov 2026Michael A. PisetskySVP, Ops & Adm/Chief Legal OfrSellplanned in advance (10b5-1)29,665$22.11$656KForm 4

177 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 32 opened a position, 21 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
First Light Asset Management, LLC7.7M17.0%$144.5M-441K-5.4%
Cadian Capital Management, LP3.8M8.40%$71.3M+444K+13%
BlackRock, Inc.3.7M8.25%$70.0M+48K+1.3%
American Century Companies Inc2.5M5.59%$47.4M+9,871+0.4%
Brown Advisory Inc2.0M4.33%$36.7M-126K-6.1%
Vanguard Capital Management LLC1.9M4.19%$35.5M+52K+2.8%
Impax Asset Management Group plc1.4M3.16%$26.8MNo change
Gilder Gagnon Howe & Co LLC1.3M2.94%$24.9M+72K+5.8%
Nuveen, LLC1.3M2.94%$24.9M+298K+29%
State Street Corp1.2M2.75%$23.4M+28K+2.3%

Company events

All 30 company events

In 12 months: 3 major agreements, 1 director or officer change. Results releases and routine reports are left out.

FiledWhat happenedSource
11 Sep 2026Signed a major agreementSame filing: took on new debt8-K
8 Jun 2026Signed a major agreementSame filing: took on new debt, shareholder vote results8-K
23 Feb 2026Director or officer change; Signed a major agreement8-K
10 Nov 2025Director or officer change8-K
4 Aug 2025Director or officer change8-K
5 Aug 2024Director or officer change8-K
19 Jul 2024Signed a major agreementSame filing: took on new debt8-K
9 Jan 2023Signed a major agreementSame filing: took on new debt8-K

Reported lobbying spend: $10K in Q4 2025, $10K in Q3 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
19 Dec 2025EndedJeffrey J. Kimbell & Associates, Inc.for Si-Bone, Inc.issues related to the medical device industry and incentivizing new technology; issues related to reimbursement for implantable medical devicesHealth issues, Medicare/MedicaidFiling
9 Jun 2025NewJeffrey J. Kimbell & Associates, Inc.for Si-Bone, Inc.Issues related to the medical device industry and incentivizing new technology Issues related to reimbursement for implantable medical devicesHealth issues, Medicare/MedicaidFiling
1 Apr 2018EndedSi-Bone, Inc.its own lobbyistsNot statedFiling
31 Dec 2017EndedPublic Sphere, Inc.for Si-BoneGeneral company overview for members and staff.; General company overview for members and staf.Taxation, Health issues, MEDFiling
9 May 2017NewSi-Bone, Inc.its own lobbyistsReimbursement coverage for certain covered medical device proceduresHealth issues, MEDFiling
1 Mar 2017NewPublic Sphere, Inc.for Si-BoneCompany overview for members and staff.Taxation, Health issues, MEDFiling

The 5 newest of 65 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

16 May 2023confirmed

Confirmed across sources Institutional holdings and Filings + Financials

Si-Bone (SIBN): reported revenue of $32.7M for the quarter ended 31 Mar 2023, 1.5× the same quarter last year, while it saw 23 13F filers open a new position in the quarter ended 31 Mar 2023, 2.6× the same quarter last year. Two unrelated kinds of activity within 7 days.

  • Financials: Quarterly revenue change, became public on 9 May 2023
  • Institutional holdings: Many funds opening a new position, became public on 15 May 2023
2021-03-31: $20.4M2021-06-30: $22.2M2021-09-30: $22.3M2021-12-31: $25.2M2022-03-31: $22.4M2022-06-30: $25.6M2022-09-30: $26.4M2022-12-31: $32.0M2023-03-31: $32.7M
The quarter ended 31 Mar 2023 against the 8 quarters before it. this quarterearliernormal: $23.8M
See the evidence (2 changes)

Financials: Quarterly revenue change became public on 9 May 2023

Si-Bone reported revenue of $32.7M for the quarter ended 31 Mar 2023, 1.5× the same quarter last year.

This period
$32.7M (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
$23.8M
Typical spread (median absolute deviation)
$1.7M
How far from its usual level
+3.5
Same quarter last year
$22.4M
History used
2,008 days
2021-03-31: $20.4M2021-06-30: $22.2M2021-09-30: $22.3M2021-12-31: $25.2M2022-03-31: $22.4M2022-06-30: $25.6M2022-09-30: $26.4M2022-12-31: $32.0M2023-03-31: $32.7M
the quarter ended 31 Mar 20238 earlier quartersnormal: $23.8M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Institutional holdings: Many funds opening a new position became public on 15 May 2023

Si-Bone saw 23 13F filers open a new position in the quarter ended 31 Mar 2023, 2.6× the same quarter last year.

This period
23 (the quarter ended 31 Mar 2023)
Normal quarter (median of 8 earlier)
12
Typical spread (median absolute deviation)
2
How far from its usual level
+3.7
Same quarter last year
9
History used
1,551 days
2021-03-31: 242021-06-30: 192021-09-30: 132021-12-31: 112022-03-31: 92022-06-30: 112022-09-30: 132022-12-31: 52023-03-31: 23
the quarter ended 31 Mar 20238 earlier quartersnormal: 12

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

Check it at the source: SEC Form 13F data sets.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 5 Nov 2026Financials change

    spent $6.4M on capital projects in the quarter ended 30 Sep 2026, 2.2× the same quarter last year.

    Same quarter last year: $3.0M; its normal quarter is $2.1M.

    See the evidence
    This period
    $6.4M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $2.1M
    Typical spread (median absolute deviation)
    $669K
    How far from its usual level
    +4.3
    Same quarter last year
    $3.0M
    History used
    3,195 days
    2024-09-30: $3.0M2024-12-31: $2.3M2025-03-31: $2.1M2025-06-30: $2.1M2025-09-30: $3.0M2025-12-31: $1.3M2026-03-31: $1.1M2026-06-30: $1.5M2026-09-30: $6.4M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $2.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 10 Jun 2026Short interest and volume change

    had 5.9M shares sold short in the 29 May 2026 report, 3.2× the same report last year.

    Same report last year: 1.9M; its normal report is 2.5M.

    See the evidence
    This period
    5.9M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    2.5M
    Typical spread (median absolute deviation)
    381K
    How far from its usual level
    +6.0
    Same report last year
    1.9M
    History used
    2,767 days
    2025-05-30: 1.9M2025-06-13: 1.7M2025-06-30: 2.0M2025-07-15: 1.9M2025-07-31: 1.9M2025-08-15: 2.1M2025-08-29: 2.2M2025-09-15: 2.1M2025-09-30: 2.4M2025-10-15: 2.7M2025-10-31: 2.8M2025-11-14: 2.8M2025-11-28: 2.6M2025-12-15: 2.4M2025-12-31: 2.4M2026-01-15: 2.6M2026-01-30: 2.4M2026-02-13: 2.7M2026-02-27: 2.9M2026-03-13: 3.6M2026-03-31: 3.9M2026-04-15: 4.6M2026-04-30: 4.5M2026-05-15: 5.7M2026-05-29: 5.9M
    the 29 May 2026 report24 earlier reportsnormal: 2.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 28 May 2026Short interest and volume change

    had 5.7M shares sold short in the 15 May 2026 report, 3.5× the same report last year.

    Same report last year: 1.6M; its normal report is 2.4M.

    See the evidence
    This period
    5.7M (the 15 May 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    394K
    How far from its usual level
    +5.6
    Same report last year
    1.6M
    History used
    2,753 days
    2025-05-15: 1.6M2025-05-30: 1.9M2025-06-13: 1.7M2025-06-30: 2.0M2025-07-15: 1.9M2025-07-31: 1.9M2025-08-15: 2.1M2025-08-29: 2.2M2025-09-15: 2.1M2025-09-30: 2.4M2025-10-15: 2.7M2025-10-31: 2.8M2025-11-14: 2.8M2025-11-28: 2.6M2025-12-15: 2.4M2025-12-31: 2.4M2026-01-15: 2.6M2026-01-30: 2.4M2026-02-13: 2.7M2026-02-27: 2.9M2026-03-13: 3.6M2026-03-31: 3.9M2026-04-15: 4.6M2026-04-30: 4.5M2026-05-15: 5.7M
    the 15 May 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 12 May 2026Short interest and volume change

    had 4.5M shares sold short in the 30 Apr 2026 report, 3.0× the same report last year.

    Same report last year: 1.5M; its normal report is 2.4M.

    See the evidence
    This period
    4.5M (the 30 Apr 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    394K
    How far from its usual level
    +3.6
    Same report last year
    1.5M
    History used
    2,738 days
    2025-04-30: 1.5M2025-05-15: 1.6M2025-05-30: 1.9M2025-06-13: 1.7M2025-06-30: 2.0M2025-07-15: 1.9M2025-07-31: 1.9M2025-08-15: 2.1M2025-08-29: 2.2M2025-09-15: 2.1M2025-09-30: 2.4M2025-10-15: 2.7M2025-10-31: 2.8M2025-11-14: 2.8M2025-11-28: 2.6M2025-12-15: 2.4M2025-12-31: 2.4M2026-01-15: 2.6M2026-01-30: 2.4M2026-02-13: 2.7M2026-02-27: 2.9M2026-03-13: 3.6M2026-03-31: 3.9M2026-04-15: 4.6M2026-04-30: 4.5M
    the 30 Apr 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 25 Apr 2026Short interest and volume change

    had 4.6M shares sold short in the 15 Apr 2026 report, 3.1× the same report last year.

    Same report last year: 1.5M; its normal report is 2.4M.

    See the evidence
    This period
    4.6M (the 15 Apr 2026 report)
    Normal report (median of 24 earlier)
    2.4M
    Typical spread (median absolute deviation)
    394K
    How far from its usual level
    +3.8
    Same report last year
    1.5M
    History used
    2,723 days
    2025-04-15: 1.5M2025-04-30: 1.5M2025-05-15: 1.6M2025-05-30: 1.9M2025-06-13: 1.7M2025-06-30: 2.0M2025-07-15: 1.9M2025-07-31: 1.9M2025-08-15: 2.1M2025-08-29: 2.2M2025-09-15: 2.1M2025-09-30: 2.4M2025-10-15: 2.7M2025-10-31: 2.8M2025-11-14: 2.8M2025-11-28: 2.6M2025-12-15: 2.4M2025-12-31: 2.4M2026-01-15: 2.6M2026-01-30: 2.4M2026-02-13: 2.7M2026-02-27: 2.9M2026-03-13: 3.6M2026-03-31: 3.9M2026-04-15: 4.6M
    the 15 Apr 2026 report24 earlier reportsnormal: 2.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 23 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 23 Feb 2026Filings record

    Director or officer change

  8. 9 Jan 2026Lobbying record

    SI-BONE, INC.: lobbying engagement terminated (JEFFREY J. KIMBELL & ASSOCIATES, INC.) (dated 19 Dec 2025)

  9. 10 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 10 Nov 2025Filings record

    Director or officer change

  11. 4 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 4 Aug 2025Filings record

    Director or officer change

  13. 16 Jul 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MMM']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    4839287
  14. 3 Jul 2025Lobbying record

    SI-BONE, INC.: new lobbying registration (JEFFREY J. KIMBELL & ASSOCIATES, INC.) (dated 9 Jun 2025)

  15. 5 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 5 Aug 2024Filings record

    Director or officer change

  17. 27 Jun 2024Short interest and volume change

    had 2.4M shares sold short in the 14 Jun 2024 report, 3.2× the same report last year.

    Same report last year: 765K; its normal report is 1.0M.

    See the evidence
    This period
    2.4M (the 14 Jun 2024 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    243K
    How far from its usual level
    +3.8
    Same report last year
    765K
    History used
    2,053 days
    2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M2024-04-15: 2.6M2024-04-30: 2.8M2024-05-15: 2.8M2024-05-31: 2.7M2024-06-14: 2.4M
    the 14 Jun 2024 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 12 Jun 2024Short interest and volume change

    had 2.7M shares sold short in the 31 May 2024 report, 3.1× the same report last year.

    Same report last year: 896K; its normal report is 1.0M.

    See the evidence
    This period
    2.7M (the 31 May 2024 report)
    Normal report (median of 24 earlier)
    1.0M
    Typical spread (median absolute deviation)
    203K
    How far from its usual level
    +5.8
    Same report last year
    896K
    History used
    2,039 days
    2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M2024-04-15: 2.6M2024-04-30: 2.8M2024-05-15: 2.8M2024-05-31: 2.7M
    the 31 May 2024 report24 earlier reportsnormal: 1.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 25 May 2024Short interest and volume change

    had 2.8M shares sold short in the 15 May 2024 report, 3.6× the same report last year.

    Same report last year: 787K; its normal report is 964K.

    See the evidence
    This period
    2.8M (the 15 May 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    154K
    How far from its usual level
    +8.3
    Same report last year
    787K
    History used
    2,023 days
    2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M2024-04-15: 2.6M2024-04-30: 2.8M2024-05-15: 2.8M
    the 15 May 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 10 May 2024Short interest and volume change

    had 2.8M shares sold short in the 30 Apr 2024 report, 2.6× the same report last year.

    Same report last year: 1.1M; its normal report is 964K.

    See the evidence
    This period
    2.8M (the 30 Apr 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +9.3
    Same report last year
    1.1M
    History used
    2,008 days
    2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M2024-04-15: 2.6M2024-04-30: 2.8M
    the 30 Apr 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 25 Apr 2024Short interest and volume change

    had 2.6M shares sold short in the 15 Apr 2024 report, 2.1× the same report last year.

    Same report last year: 1.2M; its normal report is 964K.

    See the evidence
    This period
    2.6M (the 15 Apr 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +8.2
    Same report last year
    1.2M
    History used
    1,993 days
    2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M2024-04-15: 2.6M
    the 15 Apr 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 10 Apr 2024Short interest and volume change

    had 2.4M shares sold short in the 28 Mar 2024 report, 2.0× the same report last year.

    Same report last year: 1.2M; its normal report is 964K.

    See the evidence
    This period
    2.4M (the 28 Mar 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +7.4
    Same report last year
    1.2M
    History used
    1,975 days
    2023-03-31: 1.2M2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M2024-03-28: 2.4M
    the 28 Mar 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 27 Mar 2024Short interest and volume change

    had 2.5M shares sold short in the 15 Mar 2024 report, 2.3× the same report last year.

    Same report last year: 1.1M; its normal report is 964K.

    See the evidence
    This period
    2.5M (the 15 Mar 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +7.9
    Same report last year
    1.1M
    History used
    1,962 days
    2023-03-15: 1.1M2023-03-31: 1.2M2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M2024-03-15: 2.5M
    the 15 Mar 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 12 Mar 2024Short interest and volume change

    had 2.3M shares sold short in the 29 Feb 2024 report, 1.6× the same report last year.

    Same report last year: 1.5M; its normal report is 964K.

    See the evidence
    This period
    2.3M (the 29 Feb 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +6.8
    Same report last year
    1.5M
    History used
    1,947 days
    2023-02-28: 1.5M2023-03-15: 1.1M2023-03-31: 1.2M2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M2024-02-29: 2.3M
    the 29 Feb 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 28 Feb 2024Short interest and volume change

    had 2.0M shares sold short in the 15 Feb 2024 report, 1.4× the same report last year.

    Same report last year: 1.4M; its normal report is 964K.

    See the evidence
    This period
    2.0M (the 15 Feb 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +5.0
    Same report last year
    1.4M
    History used
    1,933 days
    2023-02-15: 1.4M2023-02-28: 1.5M2023-03-15: 1.1M2023-03-31: 1.2M2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M2024-02-15: 2.0M
    the 15 Feb 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 10 Feb 2024Short interest and volume change

    had 1.8M shares sold short in the 31 Jan 2024 report, 1.3× the same report last year.

    Same report last year: 1.4M; its normal report is 964K.

    See the evidence
    This period
    1.8M (the 31 Jan 2024 report)
    Normal report (median of 24 earlier)
    964K
    Typical spread (median absolute deviation)
    134K
    How far from its usual level
    +4.0
    Same report last year
    1.4M
    History used
    1,918 days
    2023-01-31: 1.4M2023-02-15: 1.4M2023-02-28: 1.5M2023-03-15: 1.1M2023-03-31: 1.2M2023-04-14: 1.2M2023-04-28: 1.1M2023-05-15: 787K2023-05-31: 896K2023-06-15: 765K2023-06-30: 834K2023-07-14: 882K2023-07-31: 1.0M2023-08-15: 956K2023-08-31: 742K2023-09-15: 840K2023-09-29: 972K2023-10-13: 1.0M2023-10-31: 866K2023-11-15: 930K2023-11-30: 947K2023-12-15: 927K2023-12-29: 1.3M2024-01-12: 1.6M2024-01-31: 1.8M
    the 31 Jan 2024 report24 earlier reportsnormal: 964K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 14 Aug 2023Institutional holdings change

    saw 60 13F filers open a new position in the quarter ended 30 Jun 2023, 5.5× the same quarter last year.

    Same quarter last year: 11; its normal quarter is 12.

    See the evidence
    This period
    60 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    12
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +16.0
    Same quarter last year
    11
    History used
    1,642 days
    2021-06-30: 192021-09-30: 132021-12-31: 112022-03-31: 92022-06-30: 112022-09-30: 132022-12-31: 52023-03-31: 232023-06-30: 60
    the quarter ended 30 Jun 20238 earlier quartersnormal: 12

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  28. 16 May 2023several at once

    reported revenue of $32.7M for the quarter ended 31 Mar 2023, 1.5× the same quarter last year, while it saw 23 13F filers open a new position in the quarter ended 31 Mar 2023, 2.6× the same quarter last year. Two unrelated kinds of activity within 7 days.

    See the evidence (2 changes)

    Financials: Quarterly revenue change became public on 9 May 2023

    Si-Bone reported revenue of $32.7M for the quarter ended 31 Mar 2023, 1.5× the same quarter last year.

    This period
    $32.7M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $23.8M
    Typical spread (median absolute deviation)
    $1.7M
    How far from its usual level
    +3.5
    Same quarter last year
    $22.4M
    History used
    2,008 days
    2021-03-31: $20.4M2021-06-30: $22.2M2021-09-30: $22.3M2021-12-31: $25.2M2022-03-31: $22.4M2022-06-30: $25.6M2022-09-30: $26.4M2022-12-31: $32.0M2023-03-31: $32.7M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $23.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Institutional holdings: Many funds opening a new position became public on 15 May 2023

    Si-Bone saw 23 13F filers open a new position in the quarter ended 31 Mar 2023, 2.6× the same quarter last year.

    This period
    23 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    12
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +3.7
    Same quarter last year
    9
    History used
    1,551 days
    2021-03-31: 242021-06-30: 192021-09-30: 132021-12-31: 112022-03-31: 92022-06-30: 112022-09-30: 132022-12-31: 52023-03-31: 23
    the quarter ended 31 Mar 20238 earlier quartersnormal: 12

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  29. 15 May 2023Institutional holdings change

    saw 23 13F filers open a new position in the quarter ended 31 Mar 2023, 2.6× the same quarter last year.

    Same quarter last year: 9; its normal quarter is 12.

    See the evidence
    This period
    23 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    12
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +3.7
    Same quarter last year
    9
    History used
    1,551 days
    2021-03-31: 242021-06-30: 192021-09-30: 132021-12-31: 112022-03-31: 92022-06-30: 112022-09-30: 132022-12-31: 52023-03-31: 23
    the quarter ended 31 Mar 20238 earlier quartersnormal: 12

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  30. 9 May 2023Financials change

    reported revenue of $32.7M for the quarter ended 31 Mar 2023, 1.5× the same quarter last year.

    Same quarter last year: $22.4M; its normal quarter is $23.8M.

    See the evidence
    This period
    $32.7M (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    $23.8M
    Typical spread (median absolute deviation)
    $1.7M
    How far from its usual level
    +3.5
    Same quarter last year
    $22.4M
    History used
    2,008 days
    2021-03-31: $20.4M2021-06-30: $22.2M2021-09-30: $22.3M2021-12-31: $25.2M2022-03-31: $22.4M2022-06-30: $25.6M2022-09-30: $26.4M2022-12-31: $32.0M2023-03-31: $32.7M
    the quarter ended 31 Mar 20238 earlier quartersnormal: $23.8M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  31. 7 Mar 2023Financials change

    reported revenue of $32.0M for the quarter ended 31 Dec 2022, 1.3× the same quarter last year.

    Same quarter last year: $25.2M; its normal quarter is $22.4M.

    See the evidence
    This period
    $32.0M (the quarter ended 31 Dec 2022)
    Normal quarter (median of 8 earlier)
    $22.4M
    Typical spread (median absolute deviation)
    $1.1M
    How far from its usual level
    +4.3
    Same quarter last year
    $25.2M
    History used
    1,918 days
    2020-12-31: $22.1M2021-03-31: $20.4M2021-06-30: $22.2M2021-09-30: $22.3M2021-12-31: $25.2M2022-03-31: $22.4M2022-06-30: $25.6M2022-09-30: $26.4M2022-12-31: $32.0M
    the quarter ended 31 Dec 20228 earlier quartersnormal: $22.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 10 Jan 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  33. 10 Jan 2022Filings record

    Director or officer change

  34. 13 Aug 2021Filings record

    A major agreement ended

  35. 20 Apr 2021Filings record

    Director or officer change

  36. 13 Apr 2021Short interest and volume change

    had 1.3M shares sold short in the 31 Mar 2021 report, 3.3× the same report last year.

    Same report last year: 388K; its normal report is 432K.

    See the evidence
    This period
    1.3M (the 31 Mar 2021 report)
    Normal report (median of 24 earlier)
    432K
    Typical spread (median absolute deviation)
    93K
    How far from its usual level
    +6.0
    Same report last year
    388K
    History used
    882 days
    2020-03-31: 388K2020-04-15: 280K2020-04-30: 343K2020-05-15: 300K2020-05-29: 413K2020-06-15: 351K2020-06-30: 654K2020-07-15: 1.0M2020-07-31: 1.3M2020-08-14: 1.0M2020-08-31: 405K2020-09-15: 339K2020-09-30: 446K2020-10-15: 401K2020-10-30: 363K2020-11-13: 396K2020-11-30: 418K2020-12-15: 521K2020-12-31: 629K2021-01-15: 525K2021-01-29: 649K2021-02-12: 681K2021-02-26: 680K2021-03-15: 741K2021-03-31: 1.3M
    the 31 Mar 2021 report24 earlier reportsnormal: 432K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 8 Mar 2021Filings record

    Director or officer change

  38. 7 Jan 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 7 Jan 2021Filings record

    Director or officer change

  40. 17 Jul 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 65 entries; narrow the window or the kind of data to see older ones.

Not listed: 437 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001459839
Ticker
SIBN
Domain
si-bone.com
Employer name
SI-BONE, Inc. (1 unverified)
Hq location
CA|SAN JOSE|95134 (1 unverified)
Lobbying client
si bone
Name
SI-BONE Deutschland GmbH, SI-BONE, Inc., SI-BONE UK LTD
Wikidata
Q106411740
  • DOL H-1B labor condition applications and PERM certifications1 data point7 Jun 2021 to 7 Jun 2021
  • Federal lobbying disclosures (LDA)6 records, 26 data points1 Mar 2017 to 31 Dec 2025
  • SEC Form 13F institutional holdings288 data points31 Dec 2018 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)110 records17 Jun 2016 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)717 data points31 Dec 2016 to 28 Oct 2026
  • SEC Form 4 insider transactions354 records, 696 data points19 Oct 2018 to 18 Nov 2026
  • FINRA short interest (twice monthly)575 data points31 Oct 2018 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4070 data points17 Oct 2018 to 20 Nov 2026